Vendor review
LiliPeptide reviews
LiliPeptide reviews from 340 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is LiliPeptide legit? See what its vials showed.
Grade A340 independent lab tests0 peptides listedShips from United States
What the lab tests show
340 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | PT-141 | 99.9 % | 12 mg of 10 mg (20 %) | Pass | View |
| Oct 12, 2026 | Cagrilintide | 99.6 % | 6 mg of 5 mg (20 %) | Pass | View |
| Oct 12, 2026 | Retatrutide | 99.8 % | 12.1 mg of 10 mg (21 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.99 % | 32.28 mg of 30 mg (8 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 99.9 % | 30.7 mg of 30 mg (2 %) | Pass | View |
| Sep 24, 2026 | Tesamorelin | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Sep 16, 2026 | Ipamorelin | 99.9 % | 5.4 mg of 5 mg (8 %) | Pass | View |
| Sep 16, 2026 | BPC-157 | 96.6 % | 11.7847 mg of 10 mg (18 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 99.55 % | 25.4846 mg of 20 mg (27 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 80.4 mg of 100 mg (-20 %) | Pass | View |
| Sep 15, 2026 | TB-500 | 53.7 % | 5.37 mg of 10 mg (-46 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Sep 9, 2026 | CJC-1295 | 10 mg | Fail | View | |
| Sep 9, 2026 | BPC-157 | 99.9 % | 9.67 mg of 10 mg (-3 %) | Pass | View |
| Sep 8, 2026 | Retatrutide | 99.8 % | 9.6 mg of 10 mg (-4 %) | Pass | View |
| Sep 5, 2026 | Retatrutide | 99.9 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Sep 4, 2026 | Retatrutide | 99.9 % | 17.8 mg of 20 mg (-11 %) | Pass | View |
| Sep 4, 2026 | Melanotan II | 99.7 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Aug 21, 2026 | Retatrutide | 99.7 % | 15.4 mg of 15 mg (3 %) | Pass | View |
| Aug 21, 2026 | GHK-Cu | 99.7 % | 81 mg of 100 mg (-19 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.7 % | 8.7 mg of 10 mg (-13 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.8 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.8 % | 22.8 mg of 20 mg (14 %) | Pass | View |
| Aug 9, 2026 | GHK-Cu | 99.7 % | 117.4 mg of 100 mg (17 %) | Pass | View |
| Aug 4, 2026 | Retatrutide | 99.6 % | 36.2 mg of 40 mg (-10 %) | Pass | View |
| Aug 3, 2026 | MOTS-c | 99.3 % | 46.5 mg of 40 mg (16 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 8.65 mg of 10 mg (-14 %) | Pass | View |
| Aug 2, 2026 | Tirzepatide | 99.9 % | 61 mg of 60 mg (2 %) | Pass | View |
| Aug 2, 2026 | Tesamorelin | 99.8 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Aug 2, 2026 | Retatrutide | 99.6 % | 9.5 mg of 20 mg (-53 %) | Pass | View |
| Jul 30, 2026 | Retatrutide | 99.9 % | 39.1 mg of 40 mg (-2 %) | Pass | View |
| Jul 30, 2026 | Tirzepatide | 99.9 % | 45.7 mg of 50 mg (-9 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 19.8 mg of 20 mg (-1 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.2 % | 13.5 mg of 10 mg (35 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.7 % | 40.8 mg of 40 mg (2 %) | Pass | View |
| Jul 17, 2026 | SS-31 | 99.9 % | 9.32 mg of 10 mg (-7 %) | Pass | View |
| Jul 14, 2026 | MOTS-c | 98 % | 48.2 mg of 40 mg (21 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jul 13, 2026 | Tesamorelin | 98.1 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 28.7 mg of 30 mg (-4 %) | Pass | View |
| Jul 13, 2026 | Tesamorelin | 99.5 % | 11.5 mg of 15 mg (-23 %) | Pass | View |
| Jul 9, 2026 | Retatrutide | 20 mg | Fail | View | |
| Jul 1, 2026 | Tirzepatide | 99.9 % | 47 mg of 40 mg (18 %) | Pass | View |
| Jun 24, 2026 | Tesamorelin | 99.6 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 9.33 mg of 10 mg (-7 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 18.7 mg of 20 mg (-7 %) | Pass | View |
| Jun 24, 2026 | TB-500 | 96 % | 5.73 mg of 5 mg (15 %) | Pass | View |
| Jun 24, 2026 | BPC-157 | 99.9 % | 4.64 mg of 5 mg (-7 %) | Pass | View |
| Jun 17, 2026 | Retatrutide | 99.9 % | 41.4 mg of 40 mg (3 %) | Pass | View |
| Jun 17, 2026 | BPC-157 | 10 mg | Fail | View | |
| Jun 16, 2026 | GHK-Cu | 99.9 % | 80.5 mg of 100 mg (-20 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 9.03 mg of 10 mg (-10 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 4.58 mg of 5 mg (-8 %) | Pass | View |
| Jun 15, 2026 | Retatrutide | 99.9 % | 18.7 mg of 20 mg (-7 %) | Pass | View |
| Jun 15, 2026 | TB-500 | 99.4 % | 9.61 mg of 10 mg (-4 %) | Pass | View |
| Jun 12, 2026 | Tirzepatide | 99.8 % | 53.3 mg of 39.97 mg (33 %) | Pass | View |
| Jun 4, 2026 | Tirzepatide | 99.8 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Jun 4, 2026 | Tirzepatide | 99.9 % | 35.2 mg of 50 mg (-30 %) | Pass | View |
| Jun 2, 2026 | GHK-Cu | 99.9 % | 83.9 mg of 100 mg (-16 %) | Pass | View |
What LiliPeptide sells
No current listings on record.
About LiliPeptide
Finnrick has tested 340 samples from LiliPeptide across 15 products.